Procter & Gamble

As tariffs loom, Gillette razor-maker P&G sources more steel from India

The stainless steel the Gillette-brand razor maker uses is highly specialised to prevent nicks and cuts and is only produced in large quantities by a handful of companies

Dividend stocks: Procter & Gamble, Jamna Auto, 5 others to remain in focus

Here is the complete list of stocks that will remain in the spotlight during trading sessions following their dividend announcements to shareholders as they go ex-date on Thursday, November 28, 2024

P&G Home FY24 results: Net profit jumps 37% to Rs 573.6 cr, revenue up 5%

Procter & Gamble Home Products Ltd has reported a 36.8 per cent increase in its net profit at Rs 573.6 crore and a 4.8 per cent rise in revenue from operations at Rs 8,756.8 crore during FY24, according to the company's filing to RoC (Registrar of Companies). The FMCG major's total income, which also includes other income, was up 11.2 per cent to Rs 9,413.02 crore during the financial year ending March 2024, according to the financial data accessed through business intelligence platform Tofler. In FY23, Procter & Gamble Home Products Ltd (PGHPL), an unlisted entity of Procter & Gamble India, had reported a net profit of Rs 419.31 crore, while its revenue from operations stood at Rs 8,352.10 crore. This P&G entity operates in the fabric and home care, baby care and hair care business of the FMCG major with brands such as Pampers, Tide, Pantene etc. PGHPL's profit before tax was up over two-fold to Rs 1,256.73 crore in FY24. Its advertising and promotional expenses were .

Unilever, Procter & Gamble face risk from Trump's threatened Mexico tariffs

Trump warned days before his win against Democrat nominee Kamala Harris that he would hit Mexico and China with 25 per cent tariffs unless both governments moved to stop the flow of fentanyl into US

Q2 results today: L&T, Tata Power, P&G, Dabur among 77 to post earnings

Q2FY25 company results: Aditya Birla Capital, Protean eGov Technologies, TTK Prestige, and New India Assurance will release their second-quarter results for the financial year 2024-25 on October 30

P&G posts surprise drop in Q1 sales on weakening demand in US, China

P&G reported a 1 per cent increase in overall organic volumes in the first quarter, while the average prices across its product categories rose 1 per cent

P&G Hygiene and Health down 4% on weak June qtr; Rs 95-dividend announced

The fall in Procter & Gamble Hygiene and Health stock came after the company announced a weak set of financial results for the fiscal and quarter ended June 30, 2024.

P&G Health Q3 results: PAT dips 21% to Rs 46 cr, revenue at Rs 252 cr

Procter & Gamble Health on Thursday said its profit after tax declined 21 per cent year-on-year to Rs 46 crore for the third quarter ended March 2024. The company, which follows the July-June financial year, reported a profit after tax (PAT) of Rs 59 core a year ago. Its revenue from operations declined to Rs 252 crore for the period under review compared to Rs 321 crore in the year-ago period, Procter & Gamble (P&G) Health said in a regulatory filing. "The company's continued efforts to strengthen our reach and distribution with a transformed go-to-market model reflected in a one-time impact on the quarter's sales owing to the transition and optimisation of trade management and inventory," P&G Health India Managing Director Milind Thatte said. "However, we have seen sales recover in the months of March and April," he added.

P&G Hygiene and Health Q3 profit falls 6.5% to Rs 154.4 cr, sales up 13.5%

Procter & Gamble Hygiene and Health Care Ltd on Tuesday reported a decline of 6.45 per cent in profit after tax at Rs 154.37 crore in the third quarter ended March 2024 on account of one-time tax impacts. The company, which follows the July-June financial year, had reported a profit after tax of Rs 165.02 crore in the corresponding quarter of the preceding fiscal. However, Procter & Gamble Hygiene and Health Care Ltd (PGHH) revenue from operations increased 13.48 per cent to Rs 1,002.17 crore during the quarter under review. It was at Rs 883.09 crore a year ago. Its Profit After Tax (PAT) of Rs 154.37 crore "was down 6 per cent vs year ago due to one-time tax impacts in the base as well as current quarters", said the earnings statement from the company which owns popular brands such as Vicks in healthcare and Whisper in feminine care. However, its PAT was "up 50 per cent operationally fuelled by product-price mix and productivity interventions", it added. PGHH's total expense

P&G raises annual core profit forecast on resilient demand, price hikes

Even as P&G raised prices of its products over the last two years, demand for its daily-use items such as big name brands Tide and Pampers has held steady

P&G Hygiene and Health Care agrees to pay Rs 36 crore to tax authorities

Procter & Gamble Hygiene and Health Care on Wednesday said it has arrived at an advanced pricing agreement with the tax authorities for certain identified transactions with the company's affiliate. "As a consequence of this agreement, an additional tax liability, approximately Rs 36 crore (including interest) is payable," the company said. However, there will be a reduction in contingent liabilities of approximately Rs 87 crore, subject to withdrawal of relevant tax litigations by the respective parties. The agreement is for financial years 2010-11 to 2018-19, said Procter & Gamble Hygiene and Health Care in a regulatory filing. "This is to inform you that the Company has arrived at an advanced pricing agreement with the tax authorities today, viz. March 26, 2024, determining appropriate transfer pricing methodology for certain identified transactions with the Company's affiliates," it said. P&G Hygiene and Health Care owns popular brands such as Vicks in healthcare and ...

P&G Health Q2 results: Net profit dips 6% to Rs 72 cr, income at Rs 315 cr

Procter & Gamble Health Ltd on Tuesday said its profit after tax declined 6 per cent to Rs 72 crore for the second quarter ended December 2023. The company had reported a Profit After Tax (PAT) of Rs 77 crore in the October-December period of the last fiscal. Total income for the period under review stood at Rs 315 crore as against Rs 314 crore in the year-ago period, Procter & Gamble Health said in a regulatory filing. The company follows a July-June financial year. "This has been a challenging quarter for the company on account of an overall slowdown in the vitamins, minerals and supplements category coupled with a delayed seasonal onset," P&G Health India MD Milind Thatte said. With improved productivity, efficiency and continued strategic investments, the company has been able to deliver a modest topline and bottomline, he added. The company said its board has declared an interim dividend of Rs 200 per share for the financial year 2023-24. Shares of the company settled

P&G to record up to $2.5 bn in Gillette writedown, operations rejig

The consumer goods giant said it would take a $1.3 billion non-cash impairment charge before tax in the current quarter ending Dec 31 on its Gillette business

P&G India announces Rs 300 cr fund for startups for supply chain solutions

FMCG maker Procter & Gamble India on Thursday announced a Rs 300 crore fund to collaborate with external partners and innovators for co-creating solutions for a modern supply chain ecosystem. P&G Supply Chain Catalyst Fund will provide an opportunity to startups and innovators to collaborate with Procter & Gamble (P&G) India on customising business solutions, accelerating its journey towards Supply 3.0 initiatives, said a statement from the company. This is a part of Rs 1,800 crore committed in business solutions through vGROW, in which the maker of brands like Gillette, Whisper, Vicks is investing in small businesses, individuals and large organisations offering innovative solutions. "The announcement is in line with the Prime Minister's Gati Shakti initiative, which is an endeavour towards multi-modal connectivity in the country that will enhance seamless movement of goods and services through targeted interventions," the statement said. Commenting on the ...

PGHH is cautiously optimistic on India's FMCG sector in the near-term

At its first-ever investor day, which the company held for both its entities - PGHH and Gillette India, the firm noted that commodity prices continue to remain high

United Breweries brings on Vivek Gupta as MD & CEO from September 25

His most recent position with P&G was as managing director for Australia and New Zealand

P&G Hygiene and Health profit jumps over 3-fold to Rs 151 cr in Jun qtr

FMCG products maker Procter & Gamble Hygiene and Health Care Ltd has reported an over three-fold rise in Profit After Tax (PAT) at Rs 151.24 crore in the June quarter. The company, which follows the July-June financial year, had reported a PAT of Rs 42.55 crore in the corresponding quarter of the previous fiscal. Its net sales were 12.31 per cent higher at Rs 848.74 crore during the quarter under review, as against Rs 755.65 crore in the year-ago period, Procter & Gamble Hygiene and Health Care Ltd (PGHH) said in a regulatory filing. "PAT for the quarter was Rs 151 crore, versus Rs 43 crore a year ago because of strong base business growth and one-time help," a PGHH earnings statement said. Its revenue from operations stood at Rs 852.53 crore, up 9.8 per cent in the June quarter. PGHH's total expense was Rs 656.05 crore in the June quarter, down 9.42 per cent as against Rs 724.31 crore a year ago. The total income of the company, which owns popular brands such as Vicks in ...

Procter & Gamble Health profit dips 27% to Rs 30 cr in April-June quarter

Procter & Gamble Health on Thursday said its profit after tax declined by 27 per cent to Rs 30 crore in the quarter ended June 2023, hit by a higher material cost and one-time employee cost. The company, which follows the July-June financial year, had reported a profit after tax (PAT) of Rs 41 crore in the same quarter last year. Total income increased to Rs 307 crore in the April-June quarter from Rs 299 crore in the year-ago period, Procter & Gamble Health said in a statement. For the year ended June 30, 2023, the company reported a PAT of Rs 229 crore, up 19 per cent from Rs 192 crore in the previous fiscal. Total income rose to Rs 1,248 crore as compared with Rs 1,128 crore in the previous year. "We continued our efforts towards brand and category development and thus delivered a strong performance in the fiscal, marked by consistent growth across all our brands," Procter & Gamble Health MD Milind Thatte stated. The quarter, however, witnessed a category slowdown ...

Stocks to Watch: Reliance, Coforge, GAIL, Vascon, Sugar stocks, P&G Health

Stocks to Watch on August 24, 2023: Coforge promoter Hulst BV is looking to offload its entire 26.63% stake in the firm via a block deal; India may ban sugar exports for the first time in 7 years

Procter - Gamble India to invest $244 mn to set up manufacturing facility

BENGALURU (Reuters) - Procter & Gamble India said it would invest 20 billion rupees ($243.79 million) to set up a personal healthcare manufacturing facility in the western state of Gujarat.